InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Josephson Neil, Directeur Médical. Director active across 2 companies, notably Zymeworks Inc.. Aggregated, 11 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €35k. History available since 6 July 2021. The latest transaction was disclosed on 10 November 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
5,885 shares0Common StockSEC:0000899243-22-039331:0
5,885 shares0Common StockSEC:0000899243-22-035813:0
5,885 shares0Common StockSEC:0000899243-22-035785:0
1,525 shares@ US$4.5110.1% of flowCommon SharesSEC:0000899243-22-025157:0
729 shares0Common SharesSEC:0000899243-22-010794:0
1,400 shares@ US$14.270.0009% mcap29.5% of flowCommon SharesSEC:0000899243-22-001679:0
Ideal exit: 4 Oct 2022 (T+270)
1,400 shares@ US$14.2726.5% of flowCommon SharesSEC:0000899243-22-001679
Ideal exit: 4 Oct 2022 (T+270)
65 shares@ US$13.940.0000% mcap1.3% of flowCommon SharesSEC:0000899243-22-001425:0
65 shares@ US$13.941.2% of flowCommon SharesSEC:0000899243-22-001425
461 shares@ US$29.4917.2% of flowCommon SharesSEC:0000899243-21-027912
461 shares@ US$29.490.0006% mcap19.2% of flowCommon SharesSEC:0000899243-21-027912:0
11 of 11 declarations
About Josephson Neil
Neil Josephson is the Chief Medical Officer at Zymeworks Inc. He is responsible for leading the company's medical and research initiatives. His expertise is crucial for the development of innovative therapeutic solutions at Zymeworks.
